This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masui, T. Articles by Imamura, M. Search for Related Content PubMed PubMed Citation Articles by Masui, T. Articles by Imamura, M.

RECK Expression in Pancreatic Cancer

Its Correlation with Lower Invasiveness and Better Prognosis¹

Departments of Surgery and Surgical Basic Science [T. M., R. D., T. K., K. F., S. T., S. N., M. K., E. T., S. T., D. I., K. K., T. M., M. W., M. I.] and Molecular Oncology [M. N.], Kyoto University Graduate School of Medicine, Sakyo, Kyoto 606-8507, Japan

Background: The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene was initially isolated as a transformation suppressor gene. The RECK gene is expressed widely in normal organs but is undetectable in many tumor-derived cell lines. When artificially expressed in such cell lines, RECK negatively regulates at least matrix metalloprotease (MMP)-9, MMP-2, and MT1-MMP activation and suppresses the invasive and metastatic potentials of these cells. Clinical relevance of these observations, however, is yet to be established. The aim of this study was to examine RECK expression in pancreatic cancer, where intensive invasiveness and metastasis are frequently observed, and investigate its clinical significance. We also analyzed the correlation between RECK expression and MMP activation.

Methods: (a) RECK expression in surgically resected tissue samples of invasive ductal carcinomas of the pancreas (n = 50) was examined immunohistochemically, and its correlation with clinicopathological factors was analyzed; and (b) gelatin zymography was used for the detection of latent and activated forms of MMP-2 and MMP-9 in some of the tissue samples (n = 33). The gelatinase activity was quantified by densitometory, and the ratio of intensity of the active MMP-2 band to the total intensity of the pro- and active MMP-2 bands was evaluated as an indicator of MMP-2 activation. The MMP-9 activation was also studied.

Results: Among the 50 ductal carcinoma samples, 26 (52%) were stained positive for RECK. In the normal pancreas, both acinar and ß cells were stained positive, but ductal cells did not. Tumors with positive RECK staining were significantly less invasive as compared with RECK-negative tumors (P = 0.0438). Importantly, patients who had tumors with high RECK expression showed significantly better prognosis than those who had RECK-negative tumors (P = 0.0463, by Log-rank test). Zymographic analysis indicated significant inverse correlation between the level of RECK expression and extent of MMP-2 activation (P = 0.0374).

Conclusions: Our findings support the hypothesis that the RECK protein has negative effects on the invasiveness of pancreatic cancer by inhibiting MMP-2 activation and suggest the potential value of RECK as a prognostic molecular marker for pancreatic cancer.

This article has been cited by other articles:

				G. Huang, Z. Hu, M. Li, Y. Cui, Y. Li, L. Guo, W. Jiang, and S. H. Lu ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity Carcinogenesis, November 1, 2007; 28(11): 2274 - 2281. [Abstract] [Full Text] [PDF]

				S. Kondo, C. Shukunami, Y. Morioka, N. Matsumoto, R. Takahashi, J. Oh, T. Atsumi, A. Umezawa, A. Kudo, H. Kitayama, et al. Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells J. Cell Sci., March 1, 2007; 120(5): 849 - 857. [Abstract] [Full Text] [PDF]

				M.-C. Hsu, H.-C. Chang, and W.-C. Hung HER-2/neu Represses the Metastasis Suppressor RECK via ERK and Sp Transcription Factors to Promote Cell Invasion J. Biol. Chem., February 24, 2006; 281(8): 4718 - 4725. [Abstract] [Full Text] [PDF]

				K. Takenaka, S. Ishikawa, K. Yanagihara, R. Miyahara, S. Hasegawa, Y. Otake, Y. Morioka, C. Takahashi, M. Noda, H. Ito, et al. Prognostic Significance of Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs Expression in Resected Pathologic Stage IIIA N2 Non-Small-Cell Lung Cancer Ann. Surg. Oncol., October 1, 2005; 12(10): 817 - 824. [Abstract] [Full Text] [PDF]

				S. Simizu, S. Takagi, Y. Tamura, and H. Osada RECK-Mediated Suppression of Tumor Cell Invasion Is Regulated by Glycosylation in Human Tumor Cell Lines Cancer Res., August 15, 2005; 65(16): 7455 - 7461. [Abstract] [Full Text] [PDF]

				T. Takeuchi, M. Hisanaga, M. Nagao, N. Ikeda, H. Fujii, F. Koyama, T. Mukogawa, H. Matsumoto, S. Kondo, C. Takahashi, et al. The Membrane-Anchored Matrix Metalloproteinase (MMP) Regulator RECK in Combination with MMP-9 Serves as an Informative Prognostic Indicator for Colorectal Cancer Clin. Cancer Res., August 15, 2004; 10(16): 5572 - 5579. [Abstract] [Full Text] [PDF]